Steve Bernstein
Analyst · SER Asset Management. Please proceed with your question
Thank you, Stan, and good afternoon. For the nine and three months ending January 31, 2020, consolidated revenue was $31.3 million and $9.6 million compared to $36.3 million and $13.2 million for the prior fiscal year. The components of revenue for the nine months period are as follows. Revenues from commercial and U.S. government satellite programs was $14.7 million compared to $17.3 million for the same period of the prior fiscal year, and accounted for approximately 47% of consolidated revenue compared to 48% for the same period of the prior fiscal year. Revenue on satellite payload contracts are recognized primarily under percentage of completion method and are recorded only in the FEI-New York segment. Revenues from non-space, U.S. government and DOD customers, which are recorded in both, the FEI-New York and FEI-Zyfer segments are $12.7 million compared to $17.1 million in the prior fiscal year and accounted for approximately 41% of consolidated revenue compared to 47% for the prior fiscal year. Other commercial industrial revenues were $3.9 million compared to $2 million in the prior fiscal year. Inter-segment revenues are eliminated in consolidation. Third quarter revenue was impacted by the conclusion of a program that has been the source of consistent technical and cost issues. Following a mutual agreement with the end customer, this program was terminated, incurring a reduction to revenue of approximately $725,000 during this quarter. For the nine and three months periods ending January 31, 2020, gross margin was $5.9 million and $3.1 million compared to $3.1 million and $4.1 million for the same periods of the previous fiscal year. Gross margin rate decreased to 18.9% and 30.3% as compared to 34.1% and 31.1% for the same periods in fiscal 2019. The gross margin and gross margin rate decreased as compared to the same periods in fiscal 2019, principally due to the program described above as well as charges detailed in the previous quarters. Despite the current quarter charge, the gross margin rates for the three months period ending January 31, 2020 remains relatively comparable to the gross margin rate for the three months period ending January 31, 2019. For the nine and three months period ending January 31, 2020, selling and general administrative expenses increased compared to the same period in fiscal 2019. For the nine months ending January 31, 2020 and 2019, SG&A expenses were approximately 26% and 22%, respectively of consolidated revenues. For the three months ended January 31, 2020 and 2019, SG&A expenses were approximately 35% and 20%, respectively of consolidated revenues. The large increase, both percentage and dollar amounts during the three months period ending January 31, 2020 was due to increases in depreciation, insurance expense, professional fees, and payroll-related expenses. Research and development expenditures represent investments intended to keep the Company’s products at the leading edge of time and frequency technology and enhance future competitiveness. The R&D rate for the nine months ended January 31, 2020 was 15% of sales compared to 14% of sales, for the same period of the previous fiscal year. The R&D rate for the three months ended January 31, 2020 was 10% of sales as compared to 14% of sales for the same period of the previous fiscal year. For the nine and three months ended January 31, 2020, the Company recorded operating losses of $7.3 million and $1.6 million, compared to $540,000 and $394,000 for the prior fiscal year. Other income consists primarily of investment income derived from the Company’s holdings of marketable securities. For the nine-month period ending January 31, 2020, other income include a dividend of $250,000 from Morion, compared to $105,000 in the prior fiscal year. Other income expense in fiscal 2019 also included certain miscellaneous income and the proceeds of an insurance policy. This yields a pre-tax loss for the nine months and three months period ending January 31, 2020, of approximately $7 million and $1.6 million compared to a pretax loss of approximately $168,000 and $261,000 for the prior year. For the nine months ending January 31, 2020, the Company recorded a tax provision of $48,000 compared to $38,000 for the same period of fiscal 2018. For the nine months ended January 31, 2020, consolidated net loss was $7.1 million or $0.78 per diluted share, compared to $168,000, or $0.02 per diluted share for the same period of the previous fiscal year. For the three months ended January 31, 2020, consolidated net loss was $1.6 million or $0.17 per diluted share, compared to $321,000 or $0.04 per diluted share for the same period of the previous fiscal year. Our fully funded backlog at the end of January 2020 was approximately $36 million, down approximately $4 million from the previous quarter. However, subsequent to quarter-end, the Company received over $3.5 million additional funding on two existing programs. The Company’s balance sheet continues to reflect the strong working capital position of approximately $40 million at January 31, 2020, debt-free and at current ratio of over 6.1 to 1. The Company believes that its liquidity is adequate to meet operation and investing needs for the next 12 months and the foreseeable future. I will turn the call back to Stan, and we look forward to your questions later.